share_log

新興市場銘柄ダイジェスト:トリプルアイズは大幅に3日続伸、BlueMemeが大幅に続落

Emerging Market Stock Digest: Triple Eyes continued to rise drastically for 3 days, and BlueMeme continued to drop drastically

Fisco Japan ·  May 29 15:31

<5026> Triple Eyes 1430 +193 <9565> GLOE 2226 +400

Markedly rose for three consecutive days. Zero Field, a subsidiary of the group (located in Minato-ku, Tokyo), has announced the opening of a containerized "Niigata datacenter" that utilizes abundant snow, river water, and cool outside air in Yuzawa-machi, Niigata Prefecture. It will be the fifth domestic datacenter. Yuzawa-machi is easily accessible from Tokyo by Shinkansen as it takes about 1 hour and 30 minutes. Furthermore, it was determined that the location is suitable for mining and AI development from the perspective of reducing the disaster risk due to the stable ground, etc.

Triple limit up GLOE limit up.

According to some media reports, the Liberal Democratic Party's Sports Nationality Survey Committee compiled a proposal that "promotes the popularization, promotion and enhancement of esports and athletes," which is considered a buying factor. According to reports, it is said that it will be submitted to the government soon with the aim of reflecting it in the Economic and Fiscal Management Guidelines "Bold Direction" to be formulated around June. GLOE is developing esports events, and the proposal seems to be bought from the perspective that it will be a tailwind for business performance.

<4069> BlueMeme 1188 -73

Significantly continued to decline. It announced that it has postponed the announcement of the fiscal year ending March 2024 earnings report, which was scheduled to be disclosed on the 28th, to the 29th. The work for the announcement was being carried out, but it is taking time to confirm the settlement of accounts. Initially, it was postponed to the 28th, as it required time for audit firms to verify the accounting policy for software license sales, assess the effects on past years, and determine the need for correction, due to the re-examination of the accounting policy for software license sales.

<4894> Qualipias 5220 +820

The highest price since listing. The Tokyo Stock Exchange has expanded the upper limit of the restriction range to 2,800 yen. The lower limit is normal at 700 yen, and the reference price is 4,400 yen. The upper limit is 7,200 yen and the lower limit is 3,700 yen. It seems that Qualipias is attracting buying due to the expectation that it will apply for approval of the manufacture and sale of iPS cell-derived myocardial cell sheets, which will be the first in the world, to the Ministry of Health, Labor and Welfare as early as June, and the inflow of investment funds.

<5242> Eyes 2107 -60

Although it briefly hit the limit up and updated its year-to-date high, it fell back in the afternoon. Since announcing the acquisition of the patent for the technology related to the advertising industry platform "Media Radar" after the end of trading on the 17th, transactions have been made one after another, such as the completion of the acquisition of cosmetic and beauty information site, the expansion of the lead generation of Media Radar's case matching function and the number of online seminar event companies. Investment funds are flowing in. The price of Eyes shares hit its lowest point since it went public on the 17th, and the feeling that it is a bargain is also pushing the buying.

<6696> TraceOP 633 +42

Significantly rebounded. It announced that it has won a system development project from a trading partner. The contract amount is 29 million yen (excluding tax), and the delivery date is scheduled for May to July. Sales will be recorded in the second quarter of the fiscal year ending January 2025, and financial estimates for the full year have been priced in. Shares of Trace on Product Co., Ltd. rose to 705 yen, a year-to-date high, on the previous day before falling sharply towards the close. It seems that there are also some dip buying.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment